{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:43:45Z","timestamp":1779230625022,"version":"3.51.4"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>The JAK2 V617F somatic variant is a well-known driver of myeloproliferative neoplasms (MPN) associated with an increased risk for athero-thrombotic cardiovascular disease. Recent studies have demonstrated its role in the development of thoracic aortic aneurysm (TAA). However, limited clinical information and level of JAK2 V617F burden have been provided for a comprehensive evaluation of potential confounders. A retrospective genotype-first study was conducted to identify carriers of the JAK2 V617F variant from an internal exome sequencing database in Yale DNA Diagnostics Lab. Additionally, the overall incidence of somatic variants in the JAK2 gene across various tissue types in the healthy population was carried out based on reanalysis of SomaMutDB and data from the UK Biobank (UKBB) cohort to compare our dataset to the population prevalence of the variant. In our database of 12,439 exomes, 594 (4.8%) were found to have a thoracic aortic aneurysm (TAA), and 12 (0.049%) were found to have a JAK2 V617F variant. Among the 12 JAK2 V617F variant carriers, five had a TAA (42%), among whom four had an ascending TAA and one had a descending TAA, with a variant allele fraction ranging from 11.2% to 20%. Among these five patients, 60% were female, and average age at diagnosis was 70 (49\u201379). The mean ascending aneurysm size was 5.05 cm (range 4.6\u20135.5 cm), and four patients had undergone surgical aortic replacement or repair. UKBB data revealed a positive correlation between the JAK2 V617F somatic variant and aortic valve disease (effect size 0.0086, p = 0.85) and TAA (effect size = 0.004, p = 0.92), although not statistically significant. An unexpectedly high prevalence of TAA in our dataset (5\/594, 0.84%) is greater than the prevalence reported before for the general population, supporting its association with TAA. JAK2 V617F may contribute a meaningful proportion of otherwise unexplained aneurysm patients. Additionally, it may imply a potential JAK2-specific disease mechanism in the developmental of TAA, which suggests a possible target of therapy that warrants further investigation.<\/jats:p>","DOI":"10.3390\/genes15070883","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T14:40:50Z","timestamp":1720449650000},"page":"883","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Somatic Variants Acquired Later in Life Associated with Thoracic Aortic Aneurysms: JAK2 V617F"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0286-6599","authenticated-orcid":false,"given":"Christina","family":"Waldron","sequence":"first","affiliation":[{"name":"Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-199X","authenticated-orcid":false,"given":"Mohammad A.","family":"Zafar","sequence":"additional","affiliation":[{"name":"Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqiong","family":"Ma","sequence":"additional","affiliation":[{"name":"DNA Diagnostics Lab, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"DNA Diagnostics Lab, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Dykas","sequence":"additional","affiliation":[{"name":"DNA Diagnostics Lab, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulat A.","family":"Ziganshin","sequence":"additional","affiliation":[{"name":"Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0422-1325","authenticated-orcid":false,"given":"Andreea","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-5854","authenticated-orcid":false,"given":"Alokkumar","family":"Jha","sequence":"additional","affiliation":[{"name":"Centre for Neurogenetics, Weill Cornell Medicine, New York, NY 10021, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Kwan","sequence":"additional","affiliation":[{"name":"Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Elefteriades","sequence":"additional","affiliation":[{"name":"Aortic Institute at Yale-New Haven Hospital, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.semtcvs.2021.02.029","article-title":"Incidence and Prevalence of Thoracic Aortic Aneurysms: A Systematic Review and Meta-analysis of Population-Based Studies","volume":"34","author":"Duarte","year":"2022","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2019.07.078","article-title":"Ascending Aortic Length and Risk of Aortic Adverse Events: The Neglected Dimension","volume":"74","author":"Wu","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jvs.2012.04.053","article-title":"Natural history of thoracic aortic aneurysms","volume":"56","author":"Kuzmik","year":"2012","journal-title":"J. Vasc. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.114.010890","article-title":"Mortality From Thoracic Aortic Diseases and Associations With Cardiovascular Risk Factors","volume":"130","author":"Sidloff","year":"2014","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/hc0202.102246","article-title":"Predicting Death in Patients With Acute Type A Aortic Dissection","volume":"105","author":"Mehta","year":"2002","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1056\/NEJM197904053001406","article-title":"The Marfan Syndrome: Diagnosis and Management","volume":"300","author":"Pyeritz","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1520\/JFS14395J","article-title":"Familial thoracic aortic aneurysms and dissections","volume":"43","author":"Prahlow","year":"1998","journal-title":"J. Forensic Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archsurg.134.4.361","article-title":"Familial patterns of thoracic aortic aneurysms","volume":"134","author":"Coady","year":"1999","journal-title":"Arch. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jacc.2018.04.089","article-title":"Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection","volume":"72","author":"Renard","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/CIRCRESAHA.121.319809","article-title":"Somatic Mutations in Cardiovascular Disease","volume":"130","author":"Heimlich","year":"2022","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.CIR.0000154569.08857.7A","article-title":"Thoracic and Abdominal Aortic Aneurysms","volume":"111","author":"Isselbacher","year":"2005","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Waldron, C., Zafar, M.A., Ziganshin, B.A., Weininger, G., Grewal, N., and Elefteriades, J.A. (2023). Evidence Accumulates: Patients with Ascending Aneurysms Are Strongly Protected from Atherosclerotic Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242115640"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3324\/haematol.2020.264085","article-title":"Crucial role of hematopoietic JAK2 V617F in the development of aortic aneurysms","volume":"106","author":"Yokokawa","year":"2021","journal-title":"Haematologica"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.23632","article-title":"Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients","volume":"89","author":"Muendlein","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.jacc.2023.03.413","article-title":"Increased Risk of Thoracic Aortic Aneurysms with JAK2 V617F","volume":"81","author":"Nakao","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e168597","DOI":"10.1172\/JCI168597","article-title":"Genetic modification of inflammation- and clonal hematopoiesis\u2013associated cardiovascular risk","volume":"133","author":"Yu","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/eurheartj\/ehad670","article-title":"Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias","volume":"45","author":"Schuermans","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkab914","article-title":"SomaMutDB: A database of somatic mutations in normal human tissues","volume":"50","author":"Sun","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_20","unstructured":"(2024, March 26). Neale Lab, UK BioBank. Available online: https:\/\/www.nealelab.is\/uk-biobank."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-022-04965-x","article-title":"The sequences of 150,119 genomes in the UK Biobank","volume":"607","author":"Halldorsson","year":"2022","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ajh.21183","article-title":"Essential thrombocythemia, polycythemia vera, and myelofibrosis: Current management and the prospect of targeted therapy","volume":"83","author":"Tefferi","year":"2008","journal-title":"Am. J. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1538-7836.2007.02424.x","article-title":"Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders","volume":"5","author":"Fiorini","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1373\/clinchem.2006.066886","article-title":"Combined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2V617F somatic single-base sequence variant","volume":"52","author":"Sidon","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2(V617F): Prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3324\/haematol.2014.107631","article-title":"JAK2V617F somatic mutation in the general population: Myeloproliferative neoplasm development and progression rate","volume":"99","author":"Nielsen","year":"2014","journal-title":"Haematologica"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood-2016-07-726448","article-title":"JAK2 V617F clonal disorders: Fate or chance?","volume":"128","author":"Vassiliou","year":"2016","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaccao.2021.01.001","article-title":"Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease","volume":"3","author":"Yokokawa","year":"2021","journal-title":"JACC CardioOncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pan, S., Wu, D., Teschendorff, A.E., Hong, T., Wang, L., Qian, M., Wang, C., and Wang, X. (2014). JAK2-centered interactome hotspot identified by an integrative network algorithm in acute Stanford type A aortic dissection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089406"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1002\/ajh.23874","article-title":"Occurrence of the JAK2 V617F mutation in patients with peripheral arterial disease","volume":"90","author":"Muendlein","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nsmb.2348","article-title":"Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F","volume":"19","author":"Bandaranayake","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1038\/s41467-022-34469-1","article-title":"JAK2V617F mutation drives vascular resident macrophages toward a pathogenic phenotype and promotes dissecting aortic aneurysm","volume":"13","author":"Vandestienne","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e010885","DOI":"10.1161\/JAHA.118.010885","article-title":"Thoracic Aortic Aneurysm Growth in Bicuspid Aortic Valve Patients: Role of Aortic Stiffness and Pulsatile Hemodynamics","volume":"8","author":"Rooprai","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.31083\/j.rcm2406178","article-title":"Implications of Bicuspid Aortic Valve Disease and Aortic Stenosis\/Insufficiency as Risk Factors for Thoracic Aortic Aneurysm","volume":"24","author":"Jabagi","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrg3118","article-title":"Rare and common variants: Twenty arguments","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajhg.2011.11.029","article-title":"Five years of GWAS discovery","volume":"90","author":"Visscher","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dudbridge, F. (2013). Power and Predictive Accuracy of Polygenic Risk Scores. PLoS Genet., 9.","DOI":"10.1371\/annotation\/b91ba224-10be-409d-93f4-7423d502cba0"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"iyad119","DOI":"10.1093\/genetics\/iyad119","article-title":"Characterization of direct and\/or indirect genetic associations for multiple traits in longitudinal studies of disease progression","volume":"225","author":"Brossard","year":"2023","journal-title":"Genetics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood.2019001113","article-title":"Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population","volume":"134","author":"Cordua","year":"2019","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3324\/haematol.2010.033191","article-title":"The JAK2 V617F somatic mutation, mortality and cancer risk in the general population","volume":"96","author":"Nielsen","year":"2011","journal-title":"Haematologica"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/7\/883\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:10:43Z","timestamp":1760109043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/7\/883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["genes15070883"],"URL":"https:\/\/doi.org\/10.3390\/genes15070883","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}